IFNG and myeloid sarcoma: NK cells contribute to MS pathogenesis by causing direct damage to CNS components (e.g., OLs) or exerting regulatory effects on autologous T cells (Th17 cells) by modulating the expression of activating and inhibitory receptors or secreting cytokines (IFNγ, IL-15, etc).